| Literature DB >> 31358566 |
Madar Talibov1, Ann Olsson1, Helen Bailey2, Friederike Erdmann1,3, Catherine Metayer4, Corrado Magnani5, Eleni Petridou6,7, Anssi Auvinen8, Logan Spector9, Jacqueline Clavel10,11, Eve Roman12, John Dockerty13, Atte Nikkilä14, Olli Lohi15, Alice Kang4, Theodora Psaltopoulou6, Lucia Miligi16, Javier Vila17, Elisabeth Cardis17, Joachim Schüz1.
Abstract
OBJECTIVES: Previously published studies on parental occupational exposure to extremely low-frequency magnetic fields (ELF-MF) and risk of acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML) in their offspring were inconsistent. We therefore evaluated this question within the Childhood Leukemia International Consortium.Entities:
Keywords: acute lymphoblastic leukemia; acute myeloid leukemia; case-control study; elf-mf; occupation
Mesh:
Year: 2019 PMID: 31358566 PMCID: PMC6817988 DOI: 10.1136/oemed-2019-105706
Source DB: PubMed Journal: Occup Environ Med ISSN: 1351-0711 Impact factor: 4.402
Characteristics of studies included in the CLIC pooled analysis of parental exposure to occupational low-frequency magnetic fields (EMF-MF) and risk of childhood leukaemia
| Country, study (years of case accrual) | Cases | Controls | Source of occupational history data | Time period(s) of interest* | Original occupational coding | Occupational conversion tool to ISCO-88 | ||
| Source | N | Source | N | |||||
| Finland | Finnish Cancer Registry | ALL: 857. | Population register centre. | 3277 | Population census records (1990, 1995, 2000, 2005 and 2010). | Extracted from census records: (1) Census record preceding conception and (2) Census record preceding pregnancy. | ISCO 1988 and | Correspondence table ISCO-08 to ISCO-88. |
| France, ADELE | Hospitals | ALL: 240. | Hospitals (same as cases). | 288 | Self-administered questionnaire, telephone or face-to-face interview. | Extracted from work history (start and end year of each job): (1) main year before conception (defined as the year of the midpoint of the year before conception) and (2) main year of pregnancy (defined as the year of the midpoint of the pregnancy). | ISCO 1988. | |
| France, ESCALE | Population-based cancer registry (nationwide). | ALL: 641. | Population quotas by age, sex and region (nationwide). | 1681 | Self-administered questionnaire, telephone or face-to-face interview. | 1. During pregnancy†. | ISCO 1968. | Correspondence table ISCO-68 to ISCO-88. |
| Germany, GCCR | Childhood cancer registry (nationwide). | ALL: 741. | German registries of residents (regional registries with national coverage). | 2457 | Self-administered questionnaire, telephone or face-to-face interview. | (1) At conception and (2) during pregnancy. | German, Bundesagentur für Arbeit. | Correspondence table to ISCO-88 obtained from Federal Statistical Office, Germany. |
| Greece, NARECHEM | Nationwide hospital cancer registry. | ALL: 140. | Hospital. | 300 | Self-administered questionnaire, telephone or face-to-face interview. | (1) One year before birth and (2) during pregnancy. | ISCO 1988. | |
| Greece, NARECHEM | Nationwide hospital cancer registry. | ALL: 957. | Hospital. | 1085 | Self-administered questionnaire, telephone or face-to-face interview. | (1) One year before birth and (2) during pregnancy. | ISCO 1968. | Correspondence table ISCO-68 to ISCO-88. |
| Italy, SETIL | Clinical cancer registry (nationwide). | ALL: 596. | Registry (nationwide). | 1044 | Self-administered questionnaire, telephone or face-to-face interview. | (1) One year before conception and (2) during pregnancy. | ISCO 1968. | Correspondence table ISCO-68 to ISCO-88. |
| New Zealand, NZCCS | Registries (nationwide) and admission/discharge system. | ALL: 97. | Birth registry (nationwide). | 303 | Self-administered questionnaire, telephone or face-to-face interview. | (1) Two years before birth and (2) during pregnancy. | UK, Standard Occupational Classification 1990. | Correspondence table to ISCO-88 obtained from Office for National Statistics, UK. |
| UK, UKCCS | Nationwide general practitioners’ registry. | ALL: 1427. | GP registries (nationwide). | 3447 | Self-administered questionnaire, telephone or face-to-face interview. | (1) Around conception and (2) during pregnancy. | UK, Standard Occupational Classification 1990. | Correspondence table to ISCO-88 obtained from Office for National Statistics, UK. |
| USA, COG-E15 | Children’s Cancer Group clinical trials. | ALL: 1910. | RDD | 1986 | Self-administered questionnaire, telephone or face-to-face interview. | Extracted from work history (start and end month, year of each job): (1) year before conception and (2) during pregnancy. | US, Department of Labour Dictionary of Occupational Titles (4th ed., rev. 1991). | Correspondence tables obtained from the National Crosswalk Center between DOT to 2000 Census codes, and 2000 Census codes to ISCO-88. |
| USA, CCLS | Hospitals. | ALL : 814. | Birth registry (state wide). | 1224 | Self-administered questionnaire, telephone or face-to-face interview. | Extracted from work history (start and end month, year of each job): (1) year before conception and (2) during pregnancy. | US, Census Occupational Classification Codes 1990. | Correspondence tables obtained from the National Crosswalk Center between 1990 Census to 2000 Census codes, and 2000 Census codes to ISCO-88. |
*Time periods of interest were: (1) around conception for the father and (2) during pregnancy for the mother.
†In France ESCALE, paternal exposure during pregnancy was used as a proxy for exposure at conception as these data were not available.
ADELE, Adele Study; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CCLS, California Childhood Leukemia Study; CLIC, Childhood Leukaemia International Consortium; COG, Children’s Oncology Group; DOT, Dictonary of Occupational Titles; ESCALE, Epidemiologic Study on Childhood Cancer and Leukemia; GCCR, German Childhood Cancer Registry; GP, General Population; ISCO, International Standard Classification of Occupations; NARECHEM, Nationwide Registry for Childhood Haematological Malignancies; NZCCS, New Zealand Childhood Cancer Study; RDD, random digit dialling; SETIL, Studio sulla Eziologia dei Tumori Infantili Linfoemopoietici; UKCCS, United Kingdom Childhood Cancer Study.
Selected sociodemographic and prenatal characteristics of the study population of the pooled analysis
| Characteristics | ALL (11 studies) | AML (10 studies) | ||||||
| Cases | Controls | Cases | Controls | |||||
| n | % | n | % | n | % | n | % | |
| Child’s characteristics | ||||||||
|
| ||||||||
| Boy | 4699 | 55.8 | 9097 | 55.3 | 483 | 52.2 | 6834 | 55.8 |
| Girl | 3721 | 44.2 | 7356 | 44.7 | 443 | 47.8 | 5412 | 44.2 |
| Age at diagnosis/index date (years)* | ||||||||
| <1 | 264 | 3.1 | 938 | 5.7 | 120 | 13.0 | 792 | 6.5 |
| 1–4 | 4515 | 53.6 | 8024 | 48.8 | 302 | 32.6 | 5741 | 46.9 |
| 5–9 | 2421 | 28.8 | 4689 | 28.5 | 228 | 24.6 | 3469 | 28.3 |
| 10–14 | 1220 | 14.5 | 2802 | 17.0 | 274 | 29.6 | 2235 | 18.3 |
| Missing | 0 | 0 | 0 | 0 | 2 | 0.2 | 9 | 0.1 |
| Year of birth | ||||||||
| ≤1980 | 446 | 5.5 | 879 | 5.3 | 59 | 6.4 | 524 | 4.3 |
| 1981–1990 | 3770 | 44.8 | 7030 | 42.7 | 329 | 35.5 | 4748 | 38.8 |
| 1991–2000 | 3258 | 38.7 | 6572 | 39.9 | 401 | 43.3 | 5553 | 45.3 |
| >2000 | 946 | 11.2 | 1972 | 12.0 | 137 | 14.8 | 1421 | 11.6 |
| Case accrual time period† | ||||||||
| 1988–1992 | 2934 | 34.8 | 4856 | 29.5 | 159 | 17.2 | 2465 | 20.1 |
| 1993–1997 | 2181 | 25.9 | 5199 | 31.6 | 345 | 37.3 | 4660 | 38.1 |
| 1998–2002 | 1611 | 19.1 | 2910 | 17.7 | 180 | 19.4 | 2422 | 19.8 |
| 2003–2007 | 1291 | 15.3 | 2754 | 16.7 | 185 | 20.0 | 2292 | 18.7 |
| 2008–2013 | 403 | 4.8 | 734 | 4.5 | 57 | 6.2 | 407 | 3.3 |
| Parental characteristics | ||||||||
| Highest level of education‡ | ||||||||
| Did not finish secondary education | 1352 | 16.1 | 2455 | 14.9 | 189 | 20.4 | 2394 | 19.5 |
| Completed secondary education | 3701 | 44.0 | 6914 | 42.0 | 363 | 39.2 | 4681 | 38.2 |
| Tertiary education | 3186 | 37.8 | 6528 | 39.7 | 346 | 37.4 | 4968 | 40.6 |
| Missing | 181 | 2.1 | 556 | 3.4 | 28 | 3.0 | 203 | 1.7 |
| Maternal job history available | ||||||||
| Yes | 7864 | 93.4 | 15 884 | 96.5 | 902 | 97.4 | 12 005 | 98.0 |
| No | 556 | 6.6 | 569 | 3.5 | 24 | 2.6 | 241 | 2.0 |
| Paternal job history available | ||||||||
| Yes | 7842 | 93.1 | 15 301 | 93.0 | 855 | 92.3 | 11 281 | 92.1 |
| No | 578 | 6.9 | 1152 | 7.0 | 71 | 7.7 | 965 | 7.9 |
| Histological subtype | ||||||||
| ALL B-lineage | 5845 | 13 815 | ||||||
| ALL T-lineage | 781 | 13 815 | ||||||
| Total | 8420 | 16 453 | 926 | 12 246 | ||||
*Child’s age at the index date: for cases, the date of diagnosis, and for controls, either the date of recruitment or the date of questionnaire return.
†Date of interview or questionnaire return for the control.
‡Based on the highest attained education level by the parents (either mother or father).
ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia.
Estimated risk of acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML) in the offspring following parental occupational exposure to extremely low-frequency magnetic fields (ELF-MF) in a pooled analysis of Childhood Leukaemia International Consortium (CLIC) studies
| ELF-MF exposure, µT | ALL | ALL T-lineage | ALL B-lineage | AML | ||||||||
| Cases/controls | OR* | 95% CI | Cases/controls | OR* | 95% CI | Cases/controls | OR* | 95% CI | Cases/controls | OR* | 95% CI | |
| Paternal ELF-MF exposure at conception† | ||||||||||||
| ≤0.2 | 6862/13 379 | 1.00 | 632/10 946 | 1.00 | 4635/10 946 | 1.00 | 723/9572 | 1.00 | ||||
| >0.2 | 980/1922 | 1.04 | 0.95 to 1.13 | 90/1717 | 0.89 | 0.70 to 1.12 | 776/1717 | 1.09 | 0.99 to 1.19 | 132/1709 | 1.06 | 0.87 to 1.29 |
| ≤0.1 | 2403/4990 | 1.00 | 185/3416 | 1.00 | 1497/3416 | 1.00 | 313/3290 | 1.00 | ||||
| >0.1–≤0.2 | 4459/8389 | 0.96 | 0.90 to 1.02 | 447/7530 | 1.04 | 0.87 to 1.24 | 3138/7530 | 0.93 | 0.86 to 1.00 | 410/6282 | 0.81 | 0.69 to 0.96 |
| >0.2–≤1 | 936/1792 | 1.03 | 0.93 to 1.13 | 88/1601 | 0.94 | 0.72 to 1.23 | 738/1601 | 1.04 | 0.93 to 1.16 | 122/1593 | 0.92 | 0.73 to 1.15 |
| >1 | 44/130 | 0.79 | 0.55 to 1.11 | 2/116 | 0.36 | 0.06 to 1.17 | 38/116 | 0.91 | 0.62 to 1.31 | 10/116 | 1.21 | 0.58 to 2.24 |
| Maternal ELF-MF exposure during pregnancy†‡ | ||||||||||||
| ≤0.2 | 7393/14 966 | 1.00 | 689/12 490 | 1.00 | 5128/12 490 | 1.00 | 857/11 296 | 1.00 | ||||
| >0.2 | 471/918 | 1.00 | 0.89 to 1.12 | 43/756 | 0.95 | 0.68 to 1.30 | 329/756 | 0.98 | 0.85 to 1.12 | 45/709 | 0.85 | 0.61 to 1.16 |
| ≤0.1 | 4313/9143 | 1.00 | 382/7239 | 1.00 | 2939/7239 | 1.00 | 564/6970 | 1.00 | ||||
| >0.1–≤0.2 | 3080/5823 | 0.98 | 0.92 to 1.04 | 307/5251 | 1.07 | 0.90 to 1.26 | 2189/5251 | 0.95 | 0.89 to 1.02 | 293/4326 | 0.89 | 0.76 to 1.04 |
| >0.2 | 471/918 | 0.99 | 0.88 to 1.11 | 43/756 | 0.98 | 0.70 to 1.35 | 329/756 | 0.96 | 0.83 to 1.10 | 45/709 | 0.82 | 0.58 to 1.11 |
*Adjusted for child’s age and sex, highest level education of either parent, case accrual time, study.
†Median of ELF-MF was used for persons with multiple exposure assignment due to ‘one-to-many’ job title conversion.
‡Due to small number of exposed cases in the category of >1 µT, it was collapsed with category of >0.2-≤1 µT.
µT, microtesla.
Figure 1Parental occupational ELF-MF exposure and acute lymphoblastic leukaemia (ALL) in the offspring. CCLS, California Childhood Leukemia Study; COG, Children’s Oncology Group; ELF-MF, extremely low-frequency magnetic field; NARECHEM, Nationwide Registry for Childhood Haematological Malignancies; SETIL, Studio sulla Eziologia dei Tumori Infantili Linfoemopoietici.
Figure 2Parental occupational ELF-MF exposure and acute myeloid leukaemia (AML) in the offspring. CCLS, California Childhood Leukemia Study; COG, Children’s Oncology Group; ELF-MF, extremely low-frequency magnetic field; NARECHEM, Nationwide Registry for Childhood Haematological Malignancies; SETIL, Studio sulla Eziologia dei Tumori Infantili Linfoemopoietici.